A physiologically based biokinetic model for estragole in rats providing a more detailed insight into dose-dependent bioactivation and detoxification

被引：0
|
作者：
Punt, A.
Freidig, A. P.
Delatour, T.
Scholz, G.
Schilter, B.
van Bladeren, P. J.
Rietjens, I. M. C. M.
机构：
[1] Wageningen Univ, Div Toxicol, Wageningen, Netherlands
[2] TNO Qual Life, Zeist, Netherlands
[3] Nestle Res Ctr, CH-1000 Lausanne, Switzerland
来源：
CHEMICO-BIOLOGICAL INTERACTIONS | 2007年 / 169卷 / 02期
关键词：
D O I：
10.1016/j.cbi.2007.06.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 13 条
  • [1] A physiologically based biokinetic model for estragole in rats providing more detailed insight in dose dependent bioactivation and detoxification
    Punt, Ans
    Freidig, Andreas
    Delatour, Thierry
    Scholz, Gabriele
    Schilter, Benoit
    van Bladeren, Peter
    Rietjens, Ivonne
    TOXICOLOGY LETTERS, 2007, 172 : S107 - S108
  • [2] A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat
    Punt, Ans
    Freidig, Andreas P.
    Delatour, Thierry
    Scholz, Gabriele
    Boersma, Marelle G.
    Schilter, Benoit
    van Bladeren, Peter J.
    Rietjens, Ivonne M. C. M.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 231 (02) : 248 - 259
  • [3] Physiologically Based Biokinetic (PBBK) Model for Safrole Bioactivation and Detoxification in Rats
    Martati, E.
    Boersma, M. G.
    Spenkelink, A.
    Khadka, D. B.
    Punt, A.
    Vervoort, J.
    van Bladeren, P. J.
    Rietjens, I. M. C. M.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2011, 24 (06) : 818 - 834
  • [4] Use of Physiologically Based Biokinetic (PBBK) Modeling to Study Estragole Bioactivation and Detoxification in Humans as Compared with Male Rats
    Punt, Ans
    Paini, Alicia
    Boersma, Marelle G.
    Freidig, Andreas P.
    Delatour, Thierry
    Scholz, Gabriele
    Schilter, Benoit
    van Bladeren, Peter J.
    Rietjens, Ivonne M. C. M.
    TOXICOLOGICAL SCIENCES, 2009, 110 (02) : 255 - 269
  • [5] Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat
    Al-Subeihi, Ala' A. A.
    Spenkelink, Bert
    Rachmawati, Novalia
    Boersma, Marelle G.
    Punt, Ans
    Vervoort, Jacques
    van Bladeren, Peter J.
    Rietjens, Ivonne M. C. M.
    TOXICOLOGY IN VITRO, 2011, 25 (01) : 267 - 285
  • [6] In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: Implications for risk assessment
    Rietjens, Ivonne M. C. M.
    Punt, Ans
    Schilter, Benoit
    Scholz, Gabriele
    Delatour, Thierry
    van Bladeren, Peter J.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2010, 54 (02) : 195 - 207
  • [7] Physiologically Based Biokinetic (PBBK) Modeling of Safrole Bioactivation and Detoxification in Humans as Compared With Rats
    Martati, Erryana
    Boersma, Marelle G.
    Spenkelink, Albertus
    Khadka, Dambar B.
    van Bladeren, Peter J.
    Rietjens, Ivonne M. C. M.
    Punt, Ans
    TOXICOLOGICAL SCIENCES, 2012, 128 (02) : 301 - 316
  • [8] A physiologically based kinetic (PBK) model for safrole bioactivation and detoxification in rat and comparison to those for estragole and methyleugenol
    Martati, E.
    Boersma, M.
    Spenkelink, A.
    Khadka, D.
    Punt, A.
    Vervoort, J.
    van Bladeren, P.
    Rietjens, I. M. C. M.
    TOXICOLOGY LETTERS, 2011, 205 : S190 - S190
  • [9] Application of a Multi-Route Physiologically Based Pharmacokinetic Model for Manganese to Evaluate Dose-Dependent Neurological Effects in Monkeys
    Schroeter, Jeffry D.
    Dorman, David C.
    Yoon, Miyoung
    Nong, Andy
    Taylor, Michael D.
    Andersen, Melvin E.
    Clewell, Harvey J., III
    TOXICOLOGICAL SCIENCES, 2012, 129 (02) : 432 - 446
  • [10] Proposed mechanistic description of dose-dependent BDE-47 urinary elimination in mice using a physiologically based pharmacokinetic model
    Emond, Claude
    Sanders, J. Michael
    Wikoff, Daniele
    Birnbaum, Linda S.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 273 (02) : 335 - 344
12